Payer+Provider's Health System Review
September 23, 2019
Medical providers receiving higher amounts of industry payments tend to bill higher drug and medical costs.
Plans are hampered by current CMS policy and provider coding that often does not reflect social needs, Urban Institute report says.
September 20, 2019
Along with addiction counseling, the drugs naltrexone, buprenorphine and methadone all have a place in treatment for opioid use disorder.
There were noteworthy differences between what physicians recorded in their EHRs vs. what observers witnessed in clinical encounters.
The expansion into the ACA for Cigna and other insurers comes at a time when CMS reports declining unsubsidized enrollment.
The maximum price that could be set is 1.2 times the average international market price.
September 19, 2019
Real-time tracking technologies allow the organization to monitor everything from patients to medical equipment.
September 18, 2019
Technology can improve internal communications to maximize reimbursement and avoid billing errors.